Michael C Davis
Overview
Explore the profile of Michael C Davis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gershuny V, Florian J, van der Schrier R, Davis M, Salcedo P, Wang C, et al.
Br J Anaesth
. 2025 Feb;
PMID: 39986981
Background: Benzodiazepines can exacerbate opioid-induced respiratory depression by furthering the decrease in central respiratory drive and causing loss of upper airway patency potentially leading to airway obstruction. This study aimed...
2.
Miller A, Berk M, Bloch G, Briquet-Laugier V, Brouillon C, Cuthbert B, et al.
Brain Behav Immun
. 2025 Jan;
125:319-329.
PMID: 39828008
Despite tremendous advancements in neuroscience, there has been limited impact on patient care. Current psychiatric treatments are largely non-specific, and drug development is hindered by outdated, overinclusive diagnostic categories and...
3.
Sworen J, Morken P, Smith A, Boyle J, Cervantes Garcia M, Kramer J, et al.
J Chromatogr A
. 2024 Sep;
1736:465369.
PMID: 39288502
Recent advances in fluoropolymer polymerization have focused on replacing perfluorinated polymerization aids (PAs) with hydrocarbon-based alternatives. Hydrocarbon PAs are vulnerable to fluorinated radicals during polymerization, leading to the creation of...
4.
Lutz J, Pratap A, Lenze E, Bestha D, Lipschitz J, Karantzoulis S, et al.
Innov Clin Neurosci
. 2023 Oct;
20(7-9):40-46.
PMID: 37817816
Objective: Recruitment of a sufficiently large and representative patient sample and its retention during central nervous system (CNS) trials presents major challenges for study sponsors. Technological advances are reshaping clinical...
5.
Florian J, van der Schrier R, Gershuny V, Davis M, Wang C, Han X, et al.
JAMA
. 2022 Oct;
328(14):1405-1414.
PMID: 36219407
Importance: Opioids can cause severe respiratory depression by suppressing feedback mechanisms that increase ventilation in response to hypercapnia. Following the addition of boxed warnings to benzodiazepine and opioid products about...
6.
Xu L, Krishna A, Stewart S, Shea K, Racz R, Weaver J, et al.
Clin Transl Sci
. 2021 Jun;
14(6):2208-2219.
PMID: 34080766
Following a decision to require label warnings for concurrent use of opioids and benzodiazepines and increased risk of respiratory depression and death, the US Food and Drug Administratioin (FDA) recognized...
7.
Xu L, Chockalingam A, Stewart S, Shea K, Matta M, Narayanasamy S, et al.
Toxicol Rep
. 2020 Feb;
7:188-197.
PMID: 32021808
Opioids and benzodiazepines were frequently co-prescribed to patients with pain and psychiatric or neurological disorders; however, co-prescription of these drugs increased the risk for severe respiratory depression and death. Consequently,...
8.
Yang Y, Davis M, Wynn J, Hellemann G, Green M, Marder S
Schizophr Res
. 2019 Feb;
208:479-480.
PMID: 30712814
No abstract available.
9.
Wynn J, Green M, Hellemann G, Karunaratne K, Davis M, Marder S
Schizophr Res
. 2017 Oct;
195:572-573.
PMID: 28965778
No abstract available.
10.
Davis M, Miller B, Kalsi J, Birkner T, Mathis M
N Engl J Med
. 2017 May;
376(26):2503-2506.
PMID: 28489481
No abstract available.